News and Events

News and Events at The Naviaux Lab


   news_and_events

News and Events

Upcoming Events 

  1. April 7, 2021—”Cell danger signaling, the healing cycle, and resilience”. Hanscom Group Zoom.
  2. April 21, 2021—”Environmental chemical effects on metabolism in health and disease. Is it safe to heal?” Hanscom Group Zoom.
  3. May 14-16, 2021—”Exposome-metabolome interactions in autism spectrum disorder—The surprising effect of low-level environmental chemical exposures”. The MINDD Forum Zoom.
  4. June 3-5, 2021—”Exposome-metabolome interactions in chronic childhood and adult disorders”. IFM Zoom.
  5. October 14-16, 2021—”Exposome-metabolome interactions in autism spectrum disorder”. Duke University.
  6. October 28-31, 2021—”The cell danger response and the rising tide of chronic disease”. Clinical and Scientific Insights (CASI) Conference, Designs for Health, Phoenix, AZ.

Past Events

  1. November 8, 2020—”Autism metabolomics and the purinergic stress response”. Synchrony 2020—A virtual symposium sponsored by the Brain Foundation
  2. November 5-8, 2020—Clinical Applications of Scientific Innovation (CASI) symposium, Phoenix, AZ—Cancelled for COVID19
  3. October 9, 2020—“Lyme metabolomics–Updates from the Naviaux Lab”. A virtual meeting sponsored by LymeMIND and the Cohen foundation.
  4. October 9, 2020—”Mitochondrial targets and defenses in the time of COVID”. A virtual symposium sponsored by the United Mitochondrial Disease Foundation
  5. October 2, 2020—”Mitochondria, Autism, the Cell Danger Response, and a Suramin Update”. A virtual autism conference sponsored by TACA.
  6. September 13, 2020—22nd Annual UCSD Christini Fund Event. First ever virtual gala.
  7. June 24-27, 2020—Annual meeting of the United Mitochondrial Disease Foundation (UMDF), MMS, and MRS. Phoenix, AZ—Cancelled for COVID19
  8. March 19-21, 2020— Mitochondrial Blocks to Healing and Regeneration. Regenerative Medicine Workshop, Charleston, SC—Cancelled for COVID19
  9. November 8-10, 2019—ASTRA Meeting on Autism Treatment, Antipurinergic Therapy for Autism, San Francisco, CA
  10. October 18-20, 2019—TACA Annual Meeting, Antipurinergic therapy for Autism, Costa Mesa, CA
  11. October 4-5, 2019—Advances in Mitochondrial Medicine, The CDR and the Healing Cycle—A new model for chronic disease pathogenesis, Dallas, TX
  12. September 20-22, 2019—20th Anniversary Lyme Disease Association annual meeting, Providence, RI
  13. September 14, 2019—Origins of the CDR Hypothesis, San Diego, CA
  14. September 6-8, 2019—FDA Workshop on Drug Development and Clinical Trials for Mitochondrial Disease, Washington, DC
  15. All Past Events